|
Role of IFNL4 in immune response to infection
|
Research Initiative
|
FDA
|
NCI
|
Analysis of human bronchial epithelial cells infected with various strains of flu virus. Analysis of unusual pattern of IFNL4 protein expression
|
|
Rural Opioid Initiative (ROI)
|
Research Initiative
|
CDC, SAMHSA
|
NIDA
|
The National Institute on Drug Abuse (NIDA), in partnership with the Appalachian Regional Commission (ARC), the Centers for Disease Control and Prevention (CDC) and the Substance Abuse and Mental Health Services Administration (SAMHSA) funded the Rural Opioid Initiative (ROI) Research Consortium to help communities develop comprehensive approaches to prevent and treat outcomes related to substance use. This biphasic, multi-site research initiative will address the rural opioid epidemic and its consequences by bringing together expert physicians, epidemiologists, and behavioral health professionals to build collaborations between state and local communities and conduct research, use findings from the rapid assessment phase to propose locally relevant intervention projects, and implement interventions over a period of three years.;
|
|
Ruth L. Kirschstein National Research Service Award Program
|
Training Initiative
|
AHRQ, HRSA
|
OD/OER
|
The National Institutes of Health (NIH) Ruth L. Kirschstein National Research Service Award program provides predoctoral and postdoctoral training to meet the nation’s need for investigators in biomedical, behavioral, and clinical research. In accordance with the Public Health Service Act and annual appropriations acts, NIH annually transfers a portion of these funds to the Agency for Healthcare Research and Quality and Health Resources and Services Administration to foster the training of health services and primary care researchers.
|
|
RxNorm
|
Resource Development
|
FDA
|
NLM
|
RxNorm provides normalized names for clinical drugs and links its names to many of the drug vocabularies commonly used in pharmacy management and drug interaction software. By providing links between these vocabularies, RxNorm can mediate messages between systems not using the same software and vocabulary.
|
|
Sabbatical in Clinical Research Management Program
|
Training Initiative
|
FDA, OS
|
CC, FIC, NCATS, NEI, NHLBI, NIAID, NIDCR, NIDDK
|
Experienced investigators come to the National Institutes of Health (NIH) to learn about management of a clinical research enterprise, including topics such as planning and budget development, protocol writing and tracking, and scientific review. Sabbaticals are self-directed, meaning that the participant chooses from a list of electives and helps determine how much time to spend studying each topic. The electives are offered by leaders at the NIH and other US Department of Health and Human Services agencies with the NIH Clinical Center being the most heavily involved.
|
|
Safe to Sleep
|
Public Education Campaign
|
CDC, HRSA
|
NICHD
|
The Safe to Sleep® campaign seeks to educate parents and caregivers about ways to reduce the risk of Sudden Infant Death Syndrome (SIDS) and other sleep-related causes of infant death, such as accidental suffocation. The National Institute of Child Health and Human Development (NICHD) offers print and electronic materials, media resources, toolkits, and a continuing education program for nurses to help spread the word about safe infant sleep. The Safe to Sleep® campaign partners with organizations to help reach various audiences, including African American, and American Indian/Alaska Native communities, which have the highest SIDS rates of any racial/ethnic group in the United States.
|
|
SAMHSA Recovery Month
|
Public Education Campaign
|
SAMHSA
|
NIDA
|
The Substance Abuse and Mental Health Services Administration (SAMHSA) holds an annual public health observance for people in recovery from substance abuse. The National Institute on Drug Abuse (NIDA) is part of SAMHSA's inter-agency planning committee and a promotional partner.
|
|
SARS-CoV-2 Interagency Group on Resistance to Medical Countermeasures (MCMs)
|
Committee, Work group, Advisory group, or Task Force
|
ASPR, CDC, FDA
|
NIAID
|
SARS-CoV-2 interagency Working Group with vaccine, therapeutics, and diagnostics subgroups
|
|
SARS-CoV-2 Assay Development, Training, and Standardization
|
Resource Development
|
FDA
|
NIAID
|
SARS-CoV-2 Assay Development, Training, and Standardization in BSL4 lab at Integrateed Research Facility, Fort Dietrick
|
|
SARS-CoV-2 Assessment of Viral Evolution Program (SAVE)
|
Committee, Work group, Advisory group, or Task Force
|
FDA, CDC, ASPR
|
NIAID
|
SAVE provides a comprehensive real-time risk assessment of emerging mutations in SARS-CoV-2 that could impact transmissibility, virulence, and susceptibility to infection- or vaccine-induced immunity. The goals of the SAVE program are to understand emerging changes in the virus that could impact transmissibility, virulence, susceptibility to convalescent and vaccine-induced immunity and diagnostic testing.;
|